San Diego Lab Touting Coronavirus Vaccine Facing Lawsuit
San Diego Lab Touting Coronavirus Vaccine Facing Lawsuit
Wednesday, June 17, 2020
KPBS
University of San Diego law professor David McGowan said there are three points to consider in class-action suits alleging securities fraud. “There's an alleged misstatement. There's an alleged correction, and then there's an allegation of motive."